Clinical Trials in California

Showing 9801-9820 of 11,359 trials

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

NCT00971048

To compare HP828-101 to standard of care for the management of partial or full thickness wounds

Healthpoint88 participantsStarted Sep 2009

Bakersfield, California, United States • Chula Vista, California, United States • Fresno, California, United States +8 more locations

COMPLETEDPhase 262 miles

Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00002756

RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one chemotherapy drug and giving them as induction intensification may kill more cancer cells. PURPOSE: This phase II trial is studying how well induction intensification works in treating infants with newly diagnosed acute lymphocytic leukemia.

Leukemia

Children's Oncology Group221 participantsStarted Jun 1996

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +137 more locations

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

Find Trials by Condition in California

Alglucosidase Alfa Temporary Access Program

Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes